NKTX Nkarta Inc

Price (delayed)

$2.49

Market cap

$122.19M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.5

Enterprise value

$170.65M

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with ...

Highlights
NKTX's EPS is up by 6% year-on-year and by 2.3% since the previous quarter
Nkarta's net income has decreased by 18% YoY but it has increased by 2.2% QoQ
NKTX's quick ratio is down by 27% year-on-year
Nkarta's equity has decreased by 26% YoY and by 7% QoQ

Key stats

What are the main financial stats of NKTX
Market
Shares outstanding
49.07M
Market cap
$122.19M
Enterprise value
$170.65M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.41
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$122.33M
EBITDA
-$115.66M
Free cash flow
-$126.52M
Per share
EPS
-$2.5
Free cash flow per share
-$2.58
Book value per share
$6.05
Revenue per share
$0
TBVPS
$8.27
Balance sheet
Total assets
$405.86M
Total liabilities
$109.05M
Debt
$89.47M
Equity
$296.82M
Working capital
$255.55M
Liquidity
Debt to equity
0.3
Current ratio
10.97
Quick ratio
10.86
Net debt/EBITDA
-0.42
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-27.7%
Return on equity
-36.7%
Return on invested capital
-26.4%
Return on capital employed
-32.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NKTX stock price

How has the Nkarta stock price performed over time
Intraday
1.22%
1 week
-3.86%
1 month
21.46%
1 year
-69.22%
YTD
-58.43%
QTD
79.14%

Financial performance

How have Nkarta's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$135.45M
Net income
-$122.33M
Gross margin
N/A
Net margin
N/A
Nkarta's operating income has decreased by 27% YoY
Nkarta's net income has decreased by 18% YoY but it has increased by 2.2% QoQ

Growth

What is Nkarta's growth rate over time

Valuation

What is Nkarta stock price valuation
P/E
N/A
P/B
0.41
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKTX's EPS is up by 6% year-on-year and by 2.3% since the previous quarter
Nkarta's equity has decreased by 26% YoY and by 7% QoQ
The P/B is 18% below the last 4 quarters average of 0.5

Efficiency

How efficient is Nkarta business performance
NKTX's return on equity is down by 15% year-on-year and by 5% since the previous quarter
The ROA has contracted by 6% YoY and by 3.4% from the previous quarter
NKTX's return on invested capital is up by 6% year-on-year but it is down by 2.3% since the previous quarter

Dividends

What is NKTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NKTX.

Financial health

How did Nkarta financials performed over time
The current ratio has contracted by 28% YoY
NKTX's quick ratio is down by 27% year-on-year
NKTX's debt is 70% smaller than its equity
NKTX's debt to equity is up by 43% year-on-year and by 7% since the previous quarter
Nkarta's equity has decreased by 26% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.